Taxonomical and ontological analysis of verified natural and laboratory human coronavirus hosts DOI Creative Commons
Yang Wang,

Muhui Ye,

Fengwei Zhang

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2023, Номер unknown

Опубликована: Фев. 6, 2023

Abstract To fully understand COVID-19, it is critical to identify and analyze all the possible hosts of SARS-CoV-2 (the pathogen COVID-19) compare them with other human coronaviruses. In this study, we collected, annotated, performed taxonomical ontological analysis reported verified for coronaviruses including SARS-CoV, MERS-CoV, SARS-CoV-2, four others that cause common cold. A total 37 natural 19 laboratory animal host were identified based on experimental or clinical evidence. Our ontology-based found susceptible animals belong therian mammals. Specifically, these include one wildlife marsupial mammal (i.e., Didelphis virginiana) 36 Eutheria mammals (a.k.a. placental mammals). The are also classified as While several non-therian (including snake, housefly, zebrafish) be likely hosts, our excluded due lack convincing Genetically modified mouse models Angiotensin-converting enzyme 2 (ACE2) dipeptidyl peptidase-4 (DPP4) protein more virulent clear symptoms. Coronaviruses often became adaptive in after a series viral passages mice. support knowledge standardization analysis, have represented annotated Coronavirus Infectious Disease Ontology (CIDO) provided ways automatically query knowledge.

Язык: Английский

SARS‐CoV‐2 and natural infection in animals DOI

Xinyu Qiu,

Yi Liu, Ailong Sha

и другие.

Journal of Medical Virology, Год журнала: 2022, Номер 95(1)

Опубликована: Сен. 19, 2022

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative agent of novel coronavirus disease (COVID-19) pandemic, which has caused serious challenges for public health systems worldwide. Due to close relationship between animals and humans, confirmed transmission from humans numerous animal species been reported. Understanding cross-species SARS-CoV-2 infection dynamics in different crucial control COVID-19 protect health. In this review, possible origins naturally susceptible are discussed. Furthermore, review categorizes by families, so as better understand animals.

Язык: Английский

Процитировано

31

Exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the endangered Iberian lynx (Lynx pardinus) DOI Creative Commons
Javier Caballero‐Gómez, David Cano‐Terriza, Joaquím Segalés

и другие.

Veterinary Microbiology, Год журнала: 2024, Номер 290, С. 110001 - 110001

Опубликована: Янв. 21, 2024

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging zoonotic virus of public and animal health concern, which felids have been suggested as potential reservoirs. Although SARS-CoV-2 exposure has detected in domestic wild captive animals belonging to Felidae family, surveillance not carried out free-ranging so far. aim the present study was assess Iberian lynx (Lynx pardinus), most endangered felid world. Between 2019 2022, we conducted a seroepidemiological 276 lynxes. Our results evidenced limited (0.4%; 95%CI: 0.0-1.1) but negligible this species, increasing host range. circulation wildlife evidences need integrated European monitoring.

Язык: Английский

Процитировано

7

Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic DOI Creative Commons
Philippe Colson, Hervé Chaudet,

Jérémy Delerce

и другие.

Journal of Infection, Год журнала: 2024, Номер 88(5), С. 106150 - 106150

Опубликована: Апрель 1, 2024

ObjectivesThe SARS-CoV-2 pandemic and large-scale genomic surveillance provided an exceptional opportunity to analyze mutations that appeared over three years in viral genomes. Here we studied their epidemic consequences for genomes from our center.MethodsWe analyzed 61,397 sequenced respiratory samples surveillance. Mutations frequencies were calculated using Nextclade, Microsoft Excel, in-house Python script.ResultsA total of 22,225 nucleotide identified, 220 (1.0%) being each at the root ≥836 genomes, classifying as 'hyperfertile'. Two seeded European pandemic: P323L RNA polymerase, associated with increased mutation rate, D614G spike improved fitness. Most 'hyperfertile' occurred areas not predicted virulence. Their mean number was 8±6 (0-22) per 1,000 nucleotides gene. They 3.7-times more frequent accessory than informational genes (13.9 versus 3.7/1,000 nucleotides). Particularly, they 4.1-times ORF8 polymerase Interestingly, stop codons present 97 positions, almost only genes, including (21/100 codons).Conclusionsmost did predict emergence a new epidemic, some indicating existence so-named 'non-virulence' genes.

Язык: Английский

Процитировано

6

SARS-CoV-2 surveillance and detection in wild, captive, and domesticated animals in Nebraska: 2021–2023 DOI Creative Commons

Duan S. Loy,

Rachael Birn,

Korakrit Poonsuk

и другие.

Frontiers in Veterinary Science, Год журнала: 2025, Номер 11

Опубликована: Янв. 3, 2025

Widespread surveillance for SARS-CoV-2 was conducted across wildlife, captive animals in zoological collections, and domestic cats Nebraska from 2021 to 2023. The goal of this effort determine the prevalence, phylogenetic spatial distribution characteristics circulating variants using various diagnostic methodologies that can utilize both antemortem postmortem samples, which may be required wildlife such as white-tailed deer. Statewide testing revealed high variation prevalence among species, with deer identified primary reservoir. In 2021, seroprevalence 63.73% (n = 91) 39.66% 237) 2022, while virus detection retropharyngeal lymph nodes (RLN) 16.35% 483) 3.61% 277) 2022. Phylogenetic analysis on 11 positive samples 2021. This presence four lineages Delta variant: AY.100, AY.119, AY.3, AY.46.4. Conversely, other species showed no detection, except cats, had a low 2.38% 628) indicating minimal exposure. identification multiple underscores need ongoing importance different methodologies. These efforts are critical understanding circulation evolution animals, informing public health strategies, mitigating risks zoonotic transmission emerging infectious diseases.

Язык: Английский

Процитировано

0

Differences between Influenza H5N1, A/H1N1 2009, and SARS-CoV-2 in a pandemic risk scenario DOI Creative Commons
Pablo I. Plaza, Sergio A. Lambertucci

Travel Medicine and Infectious Disease, Год журнала: 2025, Номер 64, С. 102811 - 102811

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

The Contentious Origins of SARS-CoV-2: A Comprehensive Review of Current Knowledge DOI Creative Commons
José L. Domingo

Опубликована: Фев. 11, 2025

The emergence of SARS-CoV-2 in late 2019 triggered a global pandemic (COVID-19) that has claimed millions lives and continues to impact public health systems worldwide. This review examines current scientific evidence regarding the virus's origins, focusing on two primary hypotheses: zoonotic spillover laboratory-related emergence. A comprehensive analysis peer-reviewed literature published between December 2023 January 2025 was conducted, identifying relevant studies through searches PubMed Scopus databases. revealed strong phylogenetic supporting natural origin, with several indicating close genetic relationships bat coronaviruses. Environmental sampling data from Huanan Seafood Market detected RNA high number environmental samples animal stalls. While preponderance supports spillover, absence definitively identified intermediate host maintains some uncertainty. concludes evidence-based recommendations for enhanced viral surveillance, implementation One Health approaches, strengthened international collaboration frameworks prevent future coronavirus pandemics.

Язык: Английский

Процитировано

0

The Contentious Origins of SARS-CoV-2: A Comprehensive Review of Current Knowledge DOI Creative Commons
José L. Domingo

Опубликована: Фев. 17, 2025

The emergence of SARS-CoV-2 in late 2019 triggered a global pandemic (COVID-19) that has claimed millions lives and continues to impact public health systems worldwide. This review examines current scientific evidence regarding the virus's origins, focusing on two primary hypotheses: zoonotic spillover laboratory-related emergence. A comprehensive analysis peer-reviewed literature primarily published between December 2023 January 2025 was conducted, identifying relevant studies through searches PubMed Scopus databases. Key earlier publications are also included provide essential background context. revealed strong phylogenetic supporting natural origin, with several indicating close genetic relationships bat coronaviruses. Environmental sampling data from Huanan Seafood Market detected RNA high number environmental samples animal stalls. While preponderance supports spillover, absence definitively identified intermediate host maintains some uncertainty. concludes evidence-based recommendations for enhanced viral surveillance, implementation One Health approaches, strengthened international collaboration frameworks prevent future coronavirus pandemics.

Язык: Английский

Процитировано

0

The Contentious Origins of SARS-CoV-2: A Comprehensive Review of Current Knowledge DOI Creative Commons
José L. Domingo

Опубликована: Фев. 19, 2025

The emergence of SARS-CoV-2 in late 2019 triggered a global pandemic (COVID-19) that has claimed millions lives and continues to impact public health systems worldwide. This review examines current scientific evidence regarding the virus's origins, focusing on two primary hypotheses: zoonotic spillover laboratory-related emergence. A comprehensive analysis peer-reviewed literature primarily published between December 2023 January 2025 was conducted, identifying relevant studies through searches PubMed Scopus databases. Key earlier publications are also included provide essential background context. revealed strong phylogenetic supporting natural origin, with several indicating close genetic relationships bat coronaviruses. Environmental sampling data from Huanan Seafood Market detected RNA high number environmental samples animal stalls. While preponderance supports spillover, absence definitively identified intermediate host maintains some uncertainty. concludes evidence-based recommendations for enhanced viral surveillance, implementation One Health approaches, strengthened international collaboration frameworks prevent future coronavirus pandemics.

Язык: Английский

Процитировано

0

Exosomes-based particles as inhalable COVID-19 vaccines DOI Creative Commons
Fan Lü, Li Wang, Xiaoju Wang

и другие.

Biomedical Technology, Год журнала: 2023, Номер 4, С. 24 - 27

Опубликована: Март 22, 2023

Coronavirus disease 2019 (COVID-19), a severely spreading pandemic, has dramatically brought physiological and economical burdens to people.Although the injectable vaccines have some achievements for coronavirus defense, they still generate accompanied pain, untoward reaction cannot take part in mucosal immunity.Inhalable vaccines, as safe, facile efficient strategy, been presented protect body from virus by inducing robust immunity.Here, we give perspective of an inhalable COVID-19 vaccine composed lung-derived exosomes (a type virus-like particle) conjugated with viral receptor-binding domain.The lungderived act carriers, such particles successfully reach at lung reveal wider distribution longer retention on respiratory mucosa.In addition, induce high production specific antibodies T cells lung, significantly protecting host against invasion.It is conceived that long-term stability wound open new avenue delivery further achieve popularization pandemic.

Язык: Английский

Процитировано

10

An Overview on Anti-COVID-19 Drug Achievements and Challenges Ahead DOI
Mehdi Valipour, Hamid Irannejad, Hossein Keyvani

и другие.

ACS Pharmacology & Translational Science, Год журнала: 2023, Номер 6(9), С. 1248 - 1265

Опубликована: Авг. 16, 2023

The appearance of several coronavirus pandemics/epidemics during the last two decades (SARS-CoV-1 in 2002, MERS-CoV 2012, and SARS-CoV-2 2019) indicates that humanity will face increasing challenges from coronaviruses future. emergence new strains with similar transmission characteristics as mortality rates to SARS-CoV-1 (∼10% mortality) or (∼35% future is a terrifying possibility. Therefore, getting enough preparations such risks an inevitable necessity. present study aims review drug achievements fight against combined perspective derived pharmacology, pharmacotherapy, medicinal chemistry insights. Appreciating all efforts made past few years, there strong evidence desired results have not yet been achieved research this area should still be pursued seriously. By expressing some pessimistic possibilities concluding discovery pharmacotherapy COVID-19 successful so far, short essay tries draw attention responsible authorities more prepared epidemics/pandemics.

Язык: Английский

Процитировано

9